MIMICC Study in Patients With Colorectal Cancer
Recruiting
N/A
Interventional Study
Colorectal Cancer
Colon Cancer
Rectal Cancers
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 2,500 (estimated)
- Sponsor
- Fondazione del Piemonte per l'Oncologia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This multicenter prospective interventional study will evaluate stool and saliva microRNA expression and microbiome composition in patients with histologically confirmed colon or rectal cancer during key phases of the diagnostic and therapeutic pathway. The study aims to confirm and refine molecular signatures associated with colorectal cancer, assess the diagnostic and prognostic potential of sal…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Histologically confirmed colon or rectal cancer on endoscopic biopsy
* Any T stage, any N stage, M0-M1, candidate for surgical intervention
* Colon tumors with indication for surgical resection with curative intent, including right hemicolectomy, left hemicolectomy, transverse…
Contacts